Physician

Michael Jude Borne, M.D.

According to 2025 Medicare claims, Michael Borne, M.D. (NPI: 1588750178) practices ophthalmology in the Jackson, MS market, with the plurality of this provider's patient population coming from Hinds, MS. This provider's primary affiliated billing organization is MISSISSIPPI RETINA ASSOCIATES,PLLC (NPI: 1740357334; TIN: 640860086) and primary practice location at 39110-2028.

Borne's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,494 traditional Medicare patients, billed 27,184 HCPCS/CPT codes, and received $5,414,266 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 983 prescription claims across 285 beneficiaries totaling $65,498 in drug costs, led by Combigan (Brimonidine Tartrate/Timolol). Open Payments data shows 60 records totaling $124,560. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$4.7M$9.3M2015 Medicare payment: $6,423,932 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $6,561,500 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $8,479,137 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $8,526,919 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $9,339,419 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $6,666,543 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $7,390,574 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $7,202,865 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,545,478 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,414,266 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,67127,439$6,423,932
20162,84628,115$6,561,500
20173,01432,557$8,479,137
20182,85431,955$8,526,919
20192,87734,006$9,339,419
20202,17722,691$6,666,543
20212,00024,773$7,390,574
20222,36525,259$7,202,865
20231,70719,755$4,545,478
20241,49427,184$5,414,266

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$60K$120K2015 Drug cost: $88,419 (USD; Tot_Drug_Cst)2016 Drug cost: $101,450 (USD; Tot_Drug_Cst)2017 Drug cost: $120,332 (USD; Tot_Drug_Cst)2018 Drug cost: $114,365 (USD; Tot_Drug_Cst)2019 Drug cost: $116,782 (USD; Tot_Drug_Cst)2020 Drug cost: $114,186 (USD; Tot_Drug_Cst)2021 Drug cost: $114,052 (USD; Tot_Drug_Cst)2022 Drug cost: $97,577 (USD; Tot_Drug_Cst)2023 Drug cost: $75,037 (USD; Tot_Drug_Cst)2024 Drug cost: $65,498 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015317975$88,419
20163371,041$101,450
20173211,227$120,332
20183211,158$114,365
20193691,242$116,782
20203201,229$114,186
20213231,236$114,052
20223281,208$97,577
20232811,098$75,037
2024285983$65,498

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg4714,723$654
67028Injection of drug into eye6612,724$94
92014Established patient complete exam of visual system272307$77
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more724941$60
92134Imaging of retina1,3673,697$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CombiganBrimonidine Tartrate/Timolol211,065$9,358
LumiganBimatoprost16720$7,607
Prednisolone AcetatePrednisolone Acetate1785,016$5,661
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol231,233$4,889
Alphagan PBrimonidine Tartrate18730$4,216

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.49$39,046Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.11$85,513Ocular Therapeutix, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael Jude Borne, M.D.?

Tedicare shows public-source Medicare data for Michael Jude Borne, M.D. (NPI 1588750178), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Jude Borne, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Jude Borne, M.D.?

Michael Jude Borne, M.D. is linked to MISSISSIPPI RETINA ASSOCIATES,PLLC (billing NPI 1740357334) in the available physician profile data.

Does Michael Jude Borne, M.D. have Open Payments data?

Michael Jude Borne, M.D. has 60 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.